Accelerate Diagnostics Pops 10% On US Emergency Use Nod For Covid-19 Testing
Regeneron, Roche Team Up To Supply Covid-19 Antibody Cocktail To World
AI Is Booming: Here Are 3 Stocks Analysts Are Betting On
AstraZeneca Gets FDA Priority Review For New Dose Of Imfinzi Cancer Drug
AZ aims to cut cancer clinic visits with new Imfinzi regimen
Could AI avert a future coronavirus pandemic?
Beijing Touts Major COVID Vaccine Milestone As China Plays 'Catch-Up' With Russia
Novavax Launches Covid-19 Vaccine Efficacy Trial In South Africa
OncoSec Prices $15M Offering; Analyst Sees Further 150% Upside Ahead
EU places firm order for AZ/Oxford Uni’s ChAdOx1 COVID-19 vaccine
Weekly Market Review: Making a Run at Record Highs
Covid-19 vaccine makers must hit U.S. timing goals for full payments
Once We Have An Approved COVID-19 Vaccine, Then What?
Russia's Top Respiratory Doc Quits Over "Gross Ethics Violations" As Duterte Says He'll Be Guinea Pig For Putin's Vaccine
Vaccine makers including Moderna must hit U.S. timing goals for full payments
Sinopharm’s potential Covid-19 vaccine triggers antibodies in clinical trials
U.S. to make coronavirus strain for possible human challenge trials
Sanofi vet Katherine Bowdish named CEO of PIC Therapeutics; As the world Terns: Liver disease biotech makes executive changes
UK signs coronavirus vaccine deals with J&J and Novavax
China Sinopharm’s potential COVID-19 vaccine triggers antibodies in clinical trials: journal
Saliva Test For COVID-19 With "Less Than 1 Second" Results Enters Trial Phase In Israel
Top U.S. health official says approval of COVID vaccines unlikely before November
America's Obesity Epidemic Threatens Effectiveness of Any COVID Vaccine
Germany Reports Biggest COVID-19 Tally In 3 Months As Outbreak Spreads "All Over The Country": Live Updates
CEO Behind 'Sputnik V' Says US Waging "Major Information Warfare" Against Russian Vaccine
Buy Novavax Stock After Unwarranted Sell-Off, Says Analyst
UPDATED: Bristol Myers Squibb commits $300 million to combat racial disparities, but declines to release own demographic data
Covid-19 roundup: Researchers call out Gilead for diversity of remdesivir trials in NEJM; Mexico in vaccine dose, trial talks
Bristol Myers Squibb commits $300 million to combat racial disparities and double number of Black, Latino executives
Novateur Ventures explores new strategy to reduce hyperinflammatory response caused by COVID-19